Samarth Kulkarni - Sep 1, 2021 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Executive Officer, Director
Signature: /s/ Michael Esposito, attorney-in-fact
Stock symbol: CRSP
Transactions as of: Sep 1, 2021
Transactions value $: -$98,241
Form type: 4
Date filed: 9/3/2021, 08:00 PM
Previous filing: Aug 6, 2021
Next filing: Oct 18, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRSP	Common Shares	Tax liability	-$98.2K	-787	-0.42%	$124.83	187K	Sep 1, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 1, 2017, the reporting person was granted 26,667 restricted stock units. On September 1, 2021, 1,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Content

On December 1, 2017, the reporting person was granted 26,667 restricted stock units. On September 1, 2021, 1,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.